Log in
Enquire now
Pyxis Oncology

Pyxis Oncology

Pyxis Oncology is a company that is developing antibody therapeutics.

OverviewStructured DataIssuesContributors

Contents

pyxisoncology.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biology
Biology
Internal medicine
Internal medicine
Biotechnology
Biotechnology
Cancer immunotherapy
Cancer immunotherapy
Immunotherapy
Immunotherapy
‌
Pharmaceuticals
Engineering
Engineering
...
Location
United States
United States
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Cambridge, Massachusetts
Cambridge, Massachusetts
0
B2X
B2B
B2B
CEO
Lara S. Sullivan
Lara S. Sullivan
‌
Lara S. Sullivan
Founder
David Steinberg
David Steinberg
Shaan Gandhi
Shaan Gandhi
John L. Flavin
John L. Flavin
Pitchbook URL
pitchbook.com/profiles...277213-06
Legal Name
Pyxis Oncology, Inc.
Date Incorporated
2018
Number of Employees (Ranges)
51 – 2000
Email Address
info@pyxisoncology.com0
jbraco@lifescicomms.com0
careers@pyxisoncology.com0
arr@lifesciadvisors.com0
Phone Number
+161745335960
Number of Employees
64
Full Address
35 Cambridgepark Drive Cambridge, MA 02140 United States
150 Cambridgepark Drive 8th Floor, Suite 2 Cambridge, MA 02140, US0
CIK Number
1,782,2230
Place of Incorporation
Delaware
Delaware
0
Investors
Perceptive Advisors
Perceptive Advisors
Longwood Fund
Longwood Fund
Ipsen
Ipsen
HBM Healthcare Investments AG
HBM Healthcare Investments AG
Pfizer Venture Investments
Pfizer Venture Investments
Leaps by Bayer
Leaps by Bayer
RA Capital Management
RA Capital Management
Janus Henderson Investors
Janus Henderson Investors
...
IRS Number
831,160,9100
Founded Date
2019
0
Total Funding Amount (USD)
174,000,000
Latest Funding Round Date
March 2021
Competitors
ChemoCentryx
ChemoCentryx
Immunophotonics
Immunophotonics
Stock Symbol
PYXS0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
‌
Thomas Civik
0
‌
Darren Cline
0
‌
Freda C. Lewis-Hall
0
‌
Lara S. Sullivan
0
CFO
‌
Pamela Connealy
Latest Funding Type
Series B
Series B
COO
‌
Ritu Shah
Country
United States
United States

Other attributes

Company Operating Status
Active
Contact Page URL
pyxisoncology.com/contact/
Market Capitalization
78,730,000
SIC Code
2,8340
Ticker Symbol
PYXS0

Pyxis Oncology is a company that is developing antibody therapeutics to improve the immune response of the body to cancer, using new insights into the tumor microenvironment.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Pyxis Oncology

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.